Literature DB >> 21673045

Establishing and sustaining a healthy vaginal environment: analysis of data from a randomized trial of periodic presumptive treatment for vaginal infections.

Jennifer E Balkus1, Barbra A Richardson, Kishorchandra Mandaliya, James Kiarie, Walter Jaoko, Jeckoniah O Ndinya-Achola, Jeanne Marrazzo, Carey Farquhar, R Scott McClelland.   

Abstract

Data from a randomized trial of oral periodic presumptive treatment (PPT) to reduce vaginal infections were analyzed to assess the effect of the intervention on a healthy vaginal environment (normal flora confirmed by Gram stain with no candidiasis or trichomoniasis). The incidence of a healthy vaginal environment was 608 cases per 100 person-years in the intervention arm and 454 cases per 100 person-years in the placebo arm (hazard ratio [HR], 1.36; 95% confidence interval [CI], 1.17-1.58). Sustained vaginal health (healthy vaginal environment for ≥3 consecutive visits) was also more frequent in the intervention arm (HR, 1.69; 95% CI, 1.23-2.33). PPT is effective at establishing and sustaining a healthy vaginal environment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21673045      PMCID: PMC3114467          DOI: 10.1093/infdis/jir241

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

2.  Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis.

Authors:  Jack D Sobel; Daron Ferris; Jane Schwebke; Paul Nyirjesy; Harold C Wiesenfeld; Jeffrey Peipert; David Soper; Suzanne E Ohmit; Sharon L Hillier
Journal:  Am J Obstet Gynecol       Date:  2006-04-21       Impact factor: 8.661

3.  Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition.

Authors:  H L Martin; B A Richardson; P M Nyange; L Lavreys; S L Hillier; B Chohan; K Mandaliya; J O Ndinya-Achola; J Bwayo; J Kreiss
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

4.  Antimicrobial resistance associated with the treatment of bacterial vaginosis.

Authors:  Richard H Beigi; Michele N Austin; Leslie A Meyn; Marijane A Krohn; Sharon L Hillier
Journal:  Am J Obstet Gynecol       Date:  2004-10       Impact factor: 8.661

5.  Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.

Authors:  R Scott McClelland; Laura Sangare; Wisal M Hassan; Ludo Lavreys; Kishorchandra Mandaliya; James Kiarie; Jeckoniah Ndinya-Achola; Walter Jaoko; Jared M Baeten
Journal:  J Infect Dis       Date:  2007-01-22       Impact factor: 5.226

6.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

7.  High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence.

Authors:  Catriona S Bradshaw; Anna N Morton; Jane Hocking; Suzanne M Garland; Margaret B Morris; Lorna M Moss; Leonie B Horvath; Irene Kuzevska; Christopher K Fairley
Journal:  J Infect Dis       Date:  2006-04-26       Impact factor: 5.226

8.  Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women.

Authors:  Barbara Van Der Pol; Cynthia Kwok; Bosny Pierre-Louis; Anne Rinaldi; Robert A Salata; Pai-Lien Chen; Janneke van de Wijgert; Francis Mmiro; Roy Mugerwa; Tsungai Chipato; Charles S Morrison
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

9.  Preparation for AIDS vaccine evaluation in Mombasa, Kenya: establishment of seronegative cohorts of commercial sex workers and trucking company employees.

Authors:  H L Martin; D J Jackson; K Mandaliya; J Bwayo; J P Rakwar; P Nyange; S Moses; J O Ndinya-Achola; K Holmes; F Plummer
Journal:  AIDS Res Hum Retroviruses       Date:  1994       Impact factor: 2.205

10.  A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases.

Authors:  Jane R Schwebke; Renee Desmond
Journal:  Am J Obstet Gynecol       Date:  2007-06       Impact factor: 8.661

View more
  6 in total

1.  Mixed vaginitis-more than coinfection and with therapeutic implications.

Authors:  Jack D Sobel; Chitra Subramanian; Betsy Foxman; Marilyn Fairfax; Scott E Gygax
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

2.  Changes in the contribution of genital tract infections to HIV acquisition among Kenyan high-risk women from 1993 to 2012.

Authors:  Linnet Masese; Jared M Baeten; Barbra A Richardson; Elizabeth Bukusi; Grace John-Stewart; Susan M Graham; Juma Shafi; James Kiarie; Julie Overbaugh; R Scott McClelland
Journal:  AIDS       Date:  2015-06-01       Impact factor: 4.177

3.  Genital infections and syndromic diagnosis among HIV-infected women in HIV care programmes in Kenya.

Authors:  Gaston Djomand; Hongjiang Gao; Benson Singa; Sureyya Hornston; Eddas Bennett; James Odek; R Scott McClelland; Grace John-Stewart; Naomi Bock
Journal:  Int J STD AIDS       Date:  2015-01-22       Impact factor: 1.359

4.  A study on vaginitis among pregnant and non-pregnant females in Alexandria, Egypt: An unexpected high rate of mixed vaginal infection.

Authors:  Sherine Mohamed Shawaky; Mariam Majed Ali Al Shammari; Manal Shafik Sewelliam; Abeer Abd El Rahim Ghazal; Ahmed Noby Amer
Journal:  AIMS Microbiol       Date:  2022-05-05

Review 5.  A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.

Authors:  Elissa Meites; Charlotte A Gaydos; Marcia M Hobbs; Patricia Kissinger; Paul Nyirjesy; Jane R Schwebke; W Evan Secor; Jack D Sobel; Kimberly A Workowski
Journal:  Clin Infect Dis       Date:  2015-12-15       Impact factor: 9.079

6.  Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.

Authors:  Andile Mtshali; James Emmanuel San; Farzana Osman; Nigel Garrett; Christina Balle; Jennifer Giandhari; Harris Onywera; Khanyisile Mngomezulu; Gugulethu Mzobe; Tulio de Oliveira; Anne Rompalo; Adrian Mindel; Salim S Abdool Karim; Jacques Ravel; Jo-Ann S Passmore; Quarraisha Abdool Karim; Heather B Jaspan; Lenine J P Liebenberg; Sinaye Ngcapu
Journal:  Front Immunol       Date:  2021-09-14       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.